Acetylcysteine - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for acetylcysteine and what is the scope of patent protection?

Acetylcysteine is the generic ingredient in eight branded drugs marketed by Cumberland Pharms, Eugia Pharma, Exela Pharma, Fresenius Kabi Usa, Glenmark Pharms Inc, Indoco, Rising, Sagent Pharms Inc, Somerset Theraps Llc, Steriscience Speclts, Zydus Pharms, Alvogen, Am Regent, Hospira, Roxane, Apothecon, DEY, Arbor Pharms Llc, Galephar, and Mead Johnson, and is included in thirty NDAs. There are eight patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Acetylcysteine has nineteen patent family members in eleven countries.

There are three drug master file entries for acetylcysteine. Sixteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for acetylcysteine

International Patents:	19
US Patents:	8
Tradenames:	8
Applicants:	20
NDAs:	30
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	16
Raw Ingredient (Bulk) Api Vendors:	158
Clinical Trials:	400
Patent Applications:	6,888
Drug Prices:	Drug price trends for acetylcysteine
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for acetylcysteine
What excipients (inactive ingredients) are in acetylcysteine?	acetylcysteine excipients list
DailyMed Link:	acetylcysteine at DailyMed

See drug prices for acetylcysteine

Recent Clinical Trials for acetylcysteine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Navamindradhiraj University	Phase 3
Air Force 986 Hospital	N/A
The First Affiliated Hospital of ShiheziI University	N/A

See all acetylcysteine clinical trials

Generic filers with tentative approvals for ACETYLCYSTEINE

Applicant	Application No.	Strength	Dosage Form
⤷ Sign Up	⤷ Sign Up	6GM/30ML (200MG/ML)	INJECTABLE;INTRAVENOUS

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for acetylcysteine

Drug Class	Antidote Antidote for Acetaminophen Overdose Mucolytic
Mechanism of Action	Reduction Activity
Physiological Effect	Decreased Respiratory Secretion Viscosity Increased Glutathione Concentration

Medical Subject Heading (MeSH) Categories for acetylcysteine

Antiviral Agents
Expectorants
Free Radical Scavengers

Anatomical Therapeutic Chemical (ATC) Classes for acetylcysteine

Paragraph IV (Patent) Challenges for ACETYLCYSTEINE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ACETADOTE	Injection	acetylcysteine	200 mg/mL, 30 mL vials	021539	3	2012-04-04

US Patents and Regulatory Information for acetylcysteine

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	ACETYLCYSTEINE	acetylcysteine	SOLUTION;INHALATION, ORAL	203853-001	Jun 21, 2012	AN	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Eugia Pharma	ACETYLCYSTEINE	acetylcysteine	INJECTABLE;INTRAVENOUS	207358-001	Feb 29, 2016	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Roxane	ACETYLCYSTEINE	acetylcysteine	SOLUTION;INHALATION, ORAL	072621-001	Sep 30, 1992		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cumberland Pharms	ACETADOTE	acetylcysteine	INJECTABLE;INTRAVENOUS	021539-001	Jan 23, 2004	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	ACETYLCYSTEINE	acetylcysteine	SOLUTION;INHALATION, ORAL	074037-001	Aug 30, 1994	AN	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alvogen	ACETYLCYSTEINE	acetylcysteine	SOLUTION;INHALATION, ORAL	204674-001	Feb 11, 2014	AN	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cumberland Pharms	ACETADOTE	acetylcysteine	INJECTABLE;INTRAVENOUS	021539-001	Jan 23, 2004	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for acetylcysteine

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Australia	2011281035	Acetycysteine compositions and methods of use thereof	⤷ Sign Up
China	103038356	Acetycysteine compositions and methods of use thereof	⤷ Sign Up
Philippines	12012501687	ACETYLCYSTEINE COMPOSITION AND USES THEREFOR	⤷ Sign Up
Canada	2619441	COMPOSITION D'ACETYLCYSTEINE ET SES UTILISATIONS (ACETYLCYSTEINE COMPOSITION AND USES THEREFOR)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2012012640		⤷ Sign Up
Hong Kong	1123972	乙酰半胱氨酸組合物及其用途 (ACETYLCYSTEINE COMPOSITION AND USES THEREFOR)	⤷ Sign Up
European Patent Office	2662077	COMPOSITION EFFERVESCENTE CONTENANT DE LA N-ACÉTYL-CYSTÉINE (EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.